Paediatric survivors beyond infancy with Stüve-Wiedemann syndrome - A case series from the West Midlands, UK

Eur J Med Genet. 2023 Aug;66(8):104788. doi: 10.1016/j.ejmg.2023.104788. Epub 2023 Jun 7.

Abstract

Stüve-Wiedemann Syndrome (STWS) is an autosomal recessive condition caused by variants in the LIFR gene, presenting with respiratory failure, hyperthermia and skeletal dysplasia in the neonatal period. Historically identified as a lethal condition, more children are now managed holistically from early in life with multidisciplinary team involvement with improved outcomes. This stems from early diagnosis, supported by molecular testing in the pre and postnatal periods. This report includes five such cases with survival in childhood to 10 years old in the UK affected by skeletal abnormalities, hyperthermia, respiratory distress and their diagnostic odyssey. All cases have a molecular diagnosis; two patients (family 1) were found to be homozygous for a novel pathogenic LIFR variant NM_002310.5:c.704G > A, p.(Trp235Ter). One patient (family 2) is compound heterozygous with the previously reported LIFR variant NM_002310.5:c.756dup p.(Lys253Ter), and a second novel variant NM_002310.5:c.397+5G > A. Two patients (family 3) are homozygous for one of the same LIFR variants NM_002310.5:c.756dup p.(Lys253Ter) as in family 2. This report discusses genotypic and phenotypic data for five patients with STWS, as well as the need for multi-disciplinary, proactive management and genetic counselling.

Keywords: Bowing of femur; Hyperpyrexia (hyperthermia); Neonatal respiratory distress; Recurrent infections; Short stature; Stüve-wiedemann syndrome; Tibia.

MeSH terms

  • Child
  • Humans
  • Infant
  • Infant, Newborn
  • Leukemia Inhibitory Factor Receptor alpha Subunit / genetics
  • Mutation
  • Osteochondrodysplasias* / diagnosis
  • Osteochondrodysplasias* / genetics
  • United Kingdom

Substances

  • Leukemia Inhibitory Factor Receptor alpha Subunit

Supplementary concepts

  • Stuve-Wiedemann syndrome